# Zentalis Pharmaceuticals, Inc.: Form 8-K, filed Jun 21, 2024

- Company: [Zentalis Pharmaceuticals, Inc.](/companies/zntl.md) (CIK 1725160)
- Form: 8-K
- Filed: 2024-06-21
- Accepted by EDGAR: Jun 21, 2024, 17:06 ET
- Period: 2024-06-21
- Accession: 0001725160-24-000140
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1725160/000172516024000140/zntl-20240621.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1725160/000172516024000140/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1725160/000172516024000140/zntl-20240621.htm

Filed Jun 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001725160-24-000140. Last ingested by Listed: Nov 10, 2026, 02:14 ET. No prices; not investment advice.
